| Services | - Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Pharmacovigilance & Drug Safety
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Bioanalysis
- Ligand-Binding Bioanalysis (Large Molecule)
- LC-MS Bioanalysis (Small Molecule)
- Biomarker Assays
- Central Laboratory Services
- Clinical Imaging Core Lab
| - Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Clinical Trial Services
- Central Laboratory Services
- Bioanalysis
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Regulatory Affairs
- Medical Writing
- Pharmacovigilance & Drug Safety
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Oncology Specialty Services
- Immunology & Inflammation Services
- Virology Services
- Ligand-Binding Bioanalysis (Large Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- LC-MS Bioanalysis (Small Molecule)
- Microbiology Services
- In Vivo PK / PD Studies
- Immunogenicity Assays (ADA / NAb)
|
|---|
| Locations | - Morrisville, Morrisville, NC, United States
- Middleton, Middleton, WI, United States
- Cambridge, Cambridge, England, United Kingdom
- Sofia, Sofia, Bulgaria
- Manila, Manila, Philippines
- Mexico City, Mexico City, Mexico
- Melbourne, Melbourne, Australia
- Bangalore, Bangalore, India
- Beijing, Beijing, China
| - Headquarters, United Kingdom
- Belgium, Belgium
- Belgium, Belgium
- France, France
- France, France
- Hungary, Hungary
- Hungary, Hungary
- Italy, Italy
- Netherlands, Netherlands
- Poland, Poland
- Serbia, Serbia
- Italy, Italy
- Netherlands, Netherlands
- Poland, Poland
- Spain, Spain
- United Kingdom, United Kingdom
- Serbia, Serbia
- Spain, Spain
- United Kingdom, United Kingdom
|
|---|